Page last updated: 2024-12-08

botrydial

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

botrydial: is produced in plant tissues infected by Botrytis cinerea; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

botrydial : A cytotoxic fungal metabolite isolated from plant tissues infected by phytopathogen Botrytis cinerea. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID185781
CHEMBL ID476877
CHEBI ID3159
SCHEMBL ID7708121
MeSH IDM0395797

Synonyms (16)

Synonym
CHEBI:3159 ,
(1s,3ar,4s,6r,7s,7as)-1,7-diformyl-7a-hydroxy-1,3,3,6-tetramethyloctahydro-1h-inden-4-yl acetate
54986-75-3
botrydial
C09622
LMPR0103640001
CHEMBL476877
unii-2vqe1z1g8q
((1s,3ar,4s,6r,7s,7ar)-1,7-diformyl-7a-hydroxy-1,3,3,6-tetramethyl-2,3a,4,5,6,7-hexahydroinden-4-yl) acetate
2vqe1z1g8q ,
SCHEMBL7708121
(1s,3ar,4s,6r,7s,7as)-4-(acetyloxy)octahydro-7a-hydroxy-1,3,3,6-tetramethyl-1h-indene-1,7-dicarboxaldehyde
botrydial [mi]
1h-indene-1,7-dicarboxaldehyde, 4-(acetyloxy)octahydro-7a-hydroxy-1,3,3,6-tetramethyl-, (1s,3ar,4s,6r,7s,7as)-
Q4948811
DTXSID20970337

Research Excerpts

Overview

Botrydial is a phytotoxic sesquiterpene generated by the necrotrophic fungus Botrytis cinerea. Botrydial induces diverse plant defense responses, such as the production of reactive oxygen species (ROS)

ExcerptReferenceRelevance
"Botrydial is a phytotoxic sesquiterpene generated by the necrotrophic fungus Botrytis cinerea that induces diverse plant defense responses, such as the production of reactive oxygen species (ROS)."( The sesquiterpene botrydial from Botrytis cinerea induces phosphatidic acid production in tomato cell suspensions.
Collado, IG; D'Ambrosio, JM; Di Palma, AA; Gonorazky, G; Lamattina, L; Laxalt, AM; Moraga, J; Sueldo, DJ, 2018
)
1.54
"Botrydial (BOT) is a non-host specific phytotoxin produced by the polyphagous phytopathogenic fungus Botrytis cinerea. "( The botrydial biosynthetic gene cluster of Botrytis cinerea displays a bipartite genomic structure and is positively regulated by the putative Zn(II)
Amselem, J; Collado, IG; Dalmais, B; Luyten, I; Moraga, J; Morgant, G; Porquier, A; Pradier, JM; Simon, A; Viaud, M, 2016
)
2.44

Treatment

ExcerptReferenceRelevance
"Upon botrydial treatments, SlPLC2-silenced-cell suspensions produce PA levels similar to wild-type cells."( The sesquiterpene botrydial from Botrytis cinerea induces phosphatidic acid production in tomato cell suspensions.
Collado, IG; D'Ambrosio, JM; Di Palma, AA; Gonorazky, G; Lamattina, L; Laxalt, AM; Moraga, J; Sueldo, DJ, 2018
)
1.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mycotoxinPoisonous substance produced by fungi.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
dialdehydeAny aldehyde with two aldehyde groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID336743Cytotoxicity against human MDA-MB-231 cells after 24 hrs by MTT assay2003Journal of natural products, Mar, Volume: 66, Issue:3
Chemical transformations on botryane skeleton. Effect on the cytotoxic activity.
AID336742Cytotoxicity against human U87MG cells after 24 hrs by MTT assay2003Journal of natural products, Mar, Volume: 66, Issue:3
Chemical transformations on botryane skeleton. Effect on the cytotoxic activity.
AID336739Cytotoxicity against HUVEC after 24 hrs by MTT assay2003Journal of natural products, Mar, Volume: 66, Issue:3
Chemical transformations on botryane skeleton. Effect on the cytotoxic activity.
AID336740Cytotoxicity against human HT1080 cells after 24 hrs by MTT assay2003Journal of natural products, Mar, Volume: 66, Issue:3
Chemical transformations on botryane skeleton. Effect on the cytotoxic activity.
AID336741Cytotoxicity against human Hs 578T cells after 24 hrs by MTT assay2003Journal of natural products, Mar, Volume: 66, Issue:3
Chemical transformations on botryane skeleton. Effect on the cytotoxic activity.
AID336738Cytotoxicity against human IMR90 cells after 24 hrs by MTT assay2003Journal of natural products, Mar, Volume: 66, Issue:3
Chemical transformations on botryane skeleton. Effect on the cytotoxic activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (23.53)29.6817
2010's10 (58.82)24.3611
2020's3 (17.65)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.72 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]